SCHEMBL2385245

SCHEMBL2385245

Cc1ccc2[nH]c3c(cc(-c4cccc(Br)c4)c(=O)n3C)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.41
▸ KDM4E B2RXH2 5/20 0.40
▸ HPGD P15428 5/20 0.40
▸ LMNA P02545 4/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ HTT P42858 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ MDH2 P40926 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2383709 0.87 KDM4E (0.41) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL3867849 0.87 KDM4E (0.50) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2385299 0.84 KDM4E (0.38) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2381235 0.83 MAP2K4 (0.52) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2383348 0.83 KIF11 (0.49) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2384517 0.83 BRD4 (0.46) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2383697 0.83 KDM4E (0.46) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2382889 0.83 KIF11 (0.45) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2383613 0.83 ALDH1A1 (0.41) KDM4EHPGDLMNANPC1RAB9A
SCHEMBL2383622 0.82 LMNA (0.43) HPGDLMNAHSD17B10SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012991-B2 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent; amidating a 2-aminoindole with an alpha-substituted-beta-hydroxy-alkyl acrylate SANOFI-AVENTIS (FR) 2011-09-06 — — US disclosed
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics SANOFI-AVENTIS (FR) 2008-09-04 — — US disclosed
US-7390818-B2 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2008-06-24 — — US disclosed
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics PNPO, PDXK, PLPBP MAOB 34/4885KDM4E 2053/4885HPGD 72/4885
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics PNPO, PLPBP, DPYD MAOB 48/4885KDM4E 2813/4885HPGD 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback